NCT04808934View on ClinicalTrials.gov

NOAC Portuguese Real World Study

WithdrawnOBSERVATIONAL

0

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions

StrokeSystemic EmbolismMajor Bleeding

Interventions

DRUG

Apixaban

Adults receiving apixaban

DRUG

dabigatran

Adults receiving dabigatran

DRUG

rivaroxaban

Adults receiving rivaroxaban

DRUG

VKAs

Adults receiving VKA

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY